ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2194

Association of Reticular Dermis and Subcutis Inflammatory Infiltrate with Musculoskeletal Involvement in Pediatric Localized Scleroderma

Deren Esencan1, Anwesha Sanyal1, Haley Havrilla2, Samantha Branton1, Theresa Hutchins1, Claudia Salgado3 and Kathryn Torok4, 1University of Pittsburgh, Pittsburgh, PA, 2Division of Rheumatology, Scleroderma Center, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, 3University of Miami Miller School of Medicine, Miami, FL, 4Division of Rheumatology, Scleroderma Center, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

Meeting: ACR Convergence 2024

Keywords: Scleroderma, Localized, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Localized scleroderma (morphea) is a rare autoimmune disorder characterized by inflammatory infiltrate and collagen deposition in the skin and connective tissue. While textbooks offer detailed descriptions of histopathologic features, larger cohort studies summarizing these findings and their clinical correlations are limited.

Methods: We conducted a cross-sectional analysis of 126 dermatopathology reports from skin biopsies of pediatric LS patients in the National Registry for Childhood Onset Scleroderma (NRCOS). Clinical data paired with biopsy reports were included. Summary statistics were used for demographic and histologic features. Chi-square tests were applied to compare histology and clinical variables, dichotomizing clinical scores, with a p-value < 0.05 considered significant.

Results: Data for the 126 LS patients were extracted and main variables summarized in Table 1.  Of the patient cohort, 72.2% were female, with an average age of onset was 8.85 years old. The most common LS subtype was linear scleroderma (62%). The degree of inflammation was mild (48.4%, n=46/95), followed by moderate (17.9%, n=17), and severe (8.4%, n=8). Sclerosis was assessed in 26% of the biopsies (n=24), with the degree of sclerosis being mild in 9.5% (n=9), moderate in 8.5% (n=8) and severe in 7.4% (n=7).

The most common location of inflammatory infiltrates was perivascular (74.7%, n=71). A larger number than expected demonstrated interstitial inflammation (32.6%, n=31). The percentage of interstitial inflammation was observed less in linear morphea (14.6% n=12/82), compared to other morphea subtypes (28.8% n=19/66).  Lymphocytes were the predominant cell type in all subtypes (90.5%), followed by plasma cells (55%). Eosinophils were more common in circumscribed morphea (13.9%) compared to other subtypes (6.6%).

A significant association was found between extracutaneous musculoskeletal manifestations and deep tissue inflammation in the reticular dermis and subcutaneous tissue (X2 (1, N = 126) = 4.993, p = .00254). The degree of inflammation corresponded with a high modified Localized Scleroderma Skin Severity Index (mLoSSI) (X2 (1, N = 80) = 4.155, p = .0415) and Physician Global Assessment of Disease Activity (PGAA) score (X2 (1, N = 77) = 4.694, p = .0302).

Conclusion: Histopathology reports provide valuable information in localized scleroderma. Especially the degree of inflammation and sclerosis, which augment clinicians’ judgment of disease activity and may influence treatment decisions. Here, 1) we substantiate that a more robust inflammatory infiltrate is associated with higher cutaneous and global disease activity score, which help guide clinicians’ treatment of LS, and 2) we identified that the location of the inflammatory infiltrate in the deeper layers of the skin may provide a warning to deeper soft tissue involvement associated with MSK manifestations of LS. This study is the largest to date summarizing histopathologic findings in pediatric LS, establishing baseline characterization and highlighting potential for further analysis.

Supporting image 1

Table 1. Demographic, Clinical, and Histopathology Features of 126 Pediatric Localized Scleroderma Patients.


Disclosures: D. Esencan: None; A. Sanyal: None; H. Havrilla: None; S. Branton: None; T. Hutchins: None; C. Salgado: None; K. Torok: None.

To cite this abstract in AMA style:

Esencan D, Sanyal A, Havrilla H, Branton S, Hutchins T, Salgado C, Torok K. Association of Reticular Dermis and Subcutis Inflammatory Infiltrate with Musculoskeletal Involvement in Pediatric Localized Scleroderma [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/association-of-reticular-dermis-and-subcutis-inflammatory-infiltrate-with-musculoskeletal-involvement-in-pediatric-localized-scleroderma/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-reticular-dermis-and-subcutis-inflammatory-infiltrate-with-musculoskeletal-involvement-in-pediatric-localized-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology